Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Sam L. Teichman, MD
Independent consultant
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barzilai Medical Center
Ashkelon, Israel
- Soroka Medical Center
Beersheba, Israel
- Rambam Medical Center
Haifa, Israel
- Hadassah University Hospital, Ein Kerem
Jerusalem, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- Kaplan Medical Center
Rehovot, Israel
- Chaim Sheba Medical Center
Tel Litwinsky, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 31 Aug 2011
- Completion
- 31 May 2026
- Last update posted
- 5 Mar 2015
- Registered enrollment
- 28
- Registry id
- NCT00956332
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.